← Leaderboards
Debra P Ritzwoller
Dana-Farber Cancer Inst
$11,334,697
Attributed
$23,455,331
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,455,331 · 5
By mechanism
UM1$15,347,102 · 1
UG1$2,357,813 · 1
UC2$2,001,097 · 1
RC2$1,999,936 · 1
R01$1,749,383 · 1
Top collaborators
- Anil Vachani5 shared
- Michael James Hassett4 shared
- Linda S Cook3 shared
- Stacey Honda3 shared
- Jane C. Weeks2 shared
- Chyke Abadama Doubeni1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Oreofe Olukemi Odejide$2,360,066
- Christopher S Lathan$822,586
- Michael James Hassett$3,146,811
- Kasisomayajula Viswanath$37,155,095
Others in their field
Top investigators on “Data Set”
- Lawrence Corey · Fred Hutchinson Cancer Center$424,653,591
- David R. Weir · University Of Michigan At Ann Arbor$412,781,191
- David Heimbrook · Leidos Biomedical Research, Inc.$409,886,450
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$348,905,121
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Research focus
Data SetResearch PersonnelMalignant Neoplasm Of LungMalignant NeoplasmsResourcesCancer Research NetworkCollaborationsCostDesignHealth SystemCaringLungCessation Of LifeMortalityBaseCohortColoradoHawaiiMalignant Neoplasm Of ProstateEarly DiagnosisCancer EtiologyEarly TreatmentCancer TypeEcosystem
Grant awards (15)
Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)$893,587
UG1 · FY2025 · CA
NOT-CA-24-111 Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)$534,586
UG1 · FY2025 · CA
Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)$929,640
UG1 · FY2024 · CA
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations$729,340
UM1 · FY2023 · CA · contact PI
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations$2,777,128
UM1 · FY2022 · CA · contact PI
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations$2,526,598
UM1 · FY2021 · CA · contact PI
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations$3,084,653
UM1 · FY2020 · CA · contact PI
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations$3,089,892
UM1 · FY2019 · CA · contact PI
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations$3,139,491
UM1 · FY2018 · CA · contact PI
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs$476,825
R01 · FY2016 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs$474,024
R01 · FY2015 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs$401,718
R01 · FY2014 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs$396,816
R01 · FY2013 · CA
Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care$2,001,097
UC2 · FY2010 · CA
Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care$1,999,936
RC2 · FY2009 · CA